U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate
The FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021, to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Janssen Biotech Inc.
White House [U.S.]
Press Briefing by White House COVID-19 Response Team and Public Health Officials
February 03, 2021 • Press Briefings – NIH, CDC
FACT SHEET: President Biden Announces Increased Vaccine Supply, Initial Launch of the Federal Retail Pharmacy Program, and Expansion of FEMA Reimbursement to States
February 02, 2021 • Statements and Releases
…Expanding Vaccine Supply: Building on last week’s announcement, the Biden-Harris Administration will increase overall, weekly vaccine supply to states, Tribes, and territories to 10.5 million doses nationwide beginning this week. This is a 22% increase since taking office on January 20. The Administration is committing to maintaining this as the minimum supply level for the next three weeks, and we will continue to work with manufacturers in their efforts to ramp up supply.
Launching First Phase of the Federal Retail Pharmacy Program for COVID-19 Vaccination: As part of the Biden-Harris Administration’s efforts to increase access to COVID-19 vaccines, starting on February 11, those eligible for the vaccine will have the opportunity to be vaccinated at select pharmacies across the country through the Federal Retail Pharmacy Program for COVID-19 Vaccination. This program is a public-private partnership with 21 national pharmacy partners and networks of independent pharmacies representing over 40,000 pharmacy locations nationwide (listed below). It is a key component of the Administration’s National Strategy to expand equitable access to vaccines for the American public…